APA

Koutras A. K., Antonacopoulou A. G., Eleftheraki A. G., Dimitrakopoulos F., Koumarianou A., Varthalitis I., Fostira F., Sgouros J., Briasoulis E., Bournakis E., Bafaloukos D., Bompolaki I., Galani E., Kalogeras K. T., Pectasides D., Fountzilas G. & Kalofonos H. P. (20130530). Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab. : The pharmacogenomics journal.

Chicago

Koutras A K, Antonacopoulou A G, Eleftheraki A G, Dimitrakopoulos F-I, Koumarianou A, Varthalitis I, Fostira F, Sgouros J, Briasoulis E, Bournakis E, Bafaloukos D, Bompolaki I, Galani E, Kalogeras K T, Pectasides D, Fountzilas G and Kalofonos H P. 20130530. Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab. : The pharmacogenomics journal.

Harvard

Koutras A. K., Antonacopoulou A. G., Eleftheraki A. G., Dimitrakopoulos F., Koumarianou A., Varthalitis I., Fostira F., Sgouros J., Briasoulis E., Bournakis E., Bafaloukos D., Bompolaki I., Galani E., Kalogeras K. T., Pectasides D., Fountzilas G. and Kalofonos H. P. (20130530). Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab. : The pharmacogenomics journal.

MLA

Koutras A K, Antonacopoulou A G, Eleftheraki A G, Dimitrakopoulos F-I, Koumarianou A, Varthalitis I, Fostira F, Sgouros J, Briasoulis E, Bournakis E, Bafaloukos D, Bompolaki I, Galani E, Kalogeras K T, Pectasides D, Fountzilas G and Kalofonos H P. Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab. : The pharmacogenomics journal. 20130530.